M11.24 Other chondrocalcinosis, hand

Name of the Condition

• Other chondrocalcinosis, hand

Summary

Other chondrocalcinosis, hand refers to the deposition of calcium-containing crystals in the hand’s joint tissues, excluding calcium pyrophosphate dihydrate (CPPD) or hydroxyapatite. This condition causes joint inflammation, pain, and potential structural damage, often mimicking other arthritic diseases. Diagnosis typically requires identifying the specific crystal type through joint fluid analysis or tissue sampling.

Causes

Other chondrocalcinosis, hand is caused by the deposition of non-CPPD, non-hydroxyapatite calcium crystals (e.g., calcium oxalate, calcium phosphate) in the hand’s cartilage, synovium, or surrounding tissues. The exact triggers vary but may include metabolic imbalances, genetic factors, or underlying systemic conditions. Crystal formation provokes an inflammatory response, leading to joint symptoms.

Risk Factors

• Metabolic disorders (e.g., hyperoxaluria, hypophosphatasia).
• Chronic kidney disease or dialysis.
• Genetic predisposition to crystal formation.
• Exposure to certain medications or toxins.
• Hand trauma or surgery.

Symptoms

• Joint pain, swelling, and stiffness in the hand.
• Warmth and redness over affected joints.
• Reduced range of motion.
• Recurrent episodes of inflammation.
• Systemic symptoms (e.g., fever) in severe cases.

Diagnosis

Diagnosis involves joint aspiration to analyze synovial fluid for crystal type, imaging (e.g., X-ray, ultrasound) to detect crystal deposits, and clinical evaluation of symptoms. Tissue sampling may be used if crystal identification is unclear.

Treatment Options

Treatment focuses on reducing inflammation and managing pain, including nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroid injections, and colchicine. Underlying metabolic or systemic conditions are addressed to prevent further crystal deposition.

Prognosis and Follow-Up

Prognosis depends on early diagnosis and management of underlying causes. Regular follow-up monitors joint function and adjusts treatment to prevent long-term damage. Recurrent episodes may require ongoing therapy.

Complications

• Chronic joint damage or deformity.
• Persistent pain or stiffness.
• Reduced hand function.
• Secondary osteoarthritis from crystal-induced inflammation.

Lifestyle & Prevention

• Manage underlying metabolic conditions (e.g., kidney disease).
• Avoid hand trauma or repetitive stress.
• Maintain a balanced diet to support joint health.
• Follow prescribed treatments to reduce crystal formation.

When to Seek Professional Help

Seek care if hand pain, swelling, or stiffness persists, worsens, or interferes with daily activities. Prompt evaluation is needed for sudden severe symptoms or signs of infection (e.g., fever, redness).

Tips for Medical Coders

Document the specific hand joint(s) affected and confirm the exclusion of CPPD or hydroxyapatite crystals. Ensure clinical notes support the diagnosis and any associated metabolic or systemic conditions for accurate coding.